CCM
MDT icon

Copeland Capital Management’s Medtronic MDT Stock Holding History

Copeland Capital Management’s Portfolio MDT Stock Details MDT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-65,804
Closed -$6.81M – 282
2021
Q4 		$6.81M Buy
65,804
+3,099
+5% +$359K 0.18% 116
2021
Q3 		$7.86M Buy
62,705
+18,899
+43% +$2.45M 0.22% 112
2021
Q2 		$5.44M Buy
43,806
+568
+1% +$71.3K 0.16% 108
2021
Q1 		$5.11M Sell
43,238
-647
-1% -$75.8K 0.16% 105
2020
Q4 		$5.14M Buy
43,885
+4,173
+11% +$459K 0.2% 99
2020
Q3 		$4.13M Sell
39,712
-256
-0.6% -$25.7K 0.18% 100
2020
Q2 		$3.67M Sell
39,968
-1,629
-4% -$156K 0.19% 100
2020
Q1 		$3.75M Buy
41,597
+7,604
+22% +$809K 0.23% 96
2019
Q4 		$3.86M Sell
33,993
-914
-3% -$100K 0.17% 106
2019
Q3 		$3.79M Sell
34,907
-25
-0.1% -$2.61K 0.2% 102
2019
Q2 		$3.4M Buy
34,932
+491
+1% +$44.8K 0.19% 105
2019
Q1 		$3.14M Sell
34,441
-35,718
-51% -$3.2M 0.2% 105
2018
Q4 		$6.38M Buy
70,159
+997
+1% +$93.2K 0.46% 76
2018
Q3 		$6.8M Sell
69,162
-603
-0.9% -$55.7K 0.41% 101
2018
Q2 		$5.97M Sell
69,765
-9,182
-12% -$767K 0.35% 102
2018
Q1 		$6.33M Buy
78,947
+2,870
+4% +$237K 0.41% 97
2017
Q4 		$6.14M Sell
76,077
-2,249
-3% -$180K 0.39% 96
2017
Q3 		$6.09M Sell
78,326
-18,429
-19% -$1.53M 0.41% 89
2017
Q2 		$8.59M Sell
96,755
-831
-0.9% -$70.1K 0.56% 79
2017
Q1 		$7.99M Buy
97,586
+8,472
+10% +$662K 0.56% 81
2016
Q4 		$6.35M Buy
89,114
+48,894
+122% +$3.84M 0.41% 90
2016
Q3 		$3.48M Sell
40,220
-9,743
-20% -$849K 0.22% 106
2016
Q2 		$4.33M Sell
49,963
-5,224
-9% -$422K 0.3% 93
2016
Q1 		$4.14M Buy
55,187
+17,364
+46% +$1.31M 0.28% 92
2015
Q4 		$2.91M Sell
37,823
-299,007
-89% -$22.5M 0.16% 109
2015
Q3 		$22.5M Buy
336,830
+90,288
+37% +$6.65M 1.38% 20
2015
Q2 		$18.3M Buy
246,542
+46,180
+23% +$3.53M 0.93% 38
2015
Q1 		$15.6M Buy
+200,362
New +$15.2M 1.04% 41

Other funds holding MDT

WA
WestEnd Advisors Charlotte, North Carolina $4.49B AUM 19.44% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Lazard Asset Management
Lazard Asset Management New York $60.8B AUM 22.47% 1-Year Est. Return

Copeland Capital Management's MDT Position: Q1 2022 in Review

Copeland Capital Management sold out of Medtronic (MDT) in Q1 2022, closing a stake of 65,804 shares — an estimated $6.81M sold.

Copeland Capital Management first reported a position in MDT in Q1 2015 and held it in 28 quarters. The position peaked at $22.5M in Q3 2015. 2,101 funds tracked by Wall St. Rank hold MDT as of Q1 2022.

  • Copeland Capital Management reported no remaining Medtronic position as of Q1 2022 after selling out during the quarter.
  • Copeland Capital Management sold 65,804 Medtronic shares in Q1 2022, an estimated $6.81M.
  • Copeland Capital Management first reported a position in Medtronic in Q1 2015 and held it in 28 quarters.
  • Copeland Capital Management's Medtronic position peaked at $22.5M in Q3 2015.
  • 2,101 funds tracked by Wall St. Rank held Medtronic as of Q1 2022.

Based on Copeland Capital Management's 13F filing for Q1 2022, filed 18 Apr 2022.